Skip to content
10-Q

Quarterly Report

CORE LABORATORIES INC. CLB

0001193125-26-198109

← back to feed
Filed
May 1, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 24, 2026 46.1M sh
Shares Diluted Q1 2026 · Mar 31, 2026 46.07M sh
Shares Diluted Q1 2026 · Mar 31, 2025 46.77M sh
Stock Repurchased Q1 2026 · Mar 31, 2026 $4M
Stock Repurchased Q1 2026 · Mar 31, 2025 $2.02M
Dividends Paid Q1 2026 · Mar 31, 2026 $460K
Dividends Paid Q1 2026 · Mar 31, 2025 $469K
Capex Q1 2026 · Mar 31, 2026 $3.45M
Capex Q1 2026 · Mar 31, 2025 $2.79M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $3.97M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $6.66M
Long Term Debt Q1 2026 · Mar 31, 2026 $114.46M
Long Term Debt Q1 2026 · Dec 31, 2025 $110.26M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $22.82M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $22.7M
Stockholders Equity Q1 2026 · Mar 31, 2026 $268.89M
Stockholders Equity Q1 2026 · Dec 31, 2025 $265.99M
Current Liabilities Q1 2026 · Mar 31, 2026 $104.73M
Current Liabilities Q1 2026 · Dec 31, 2025 $106.02M
Current Assets Q1 2026 · Mar 31, 2026 $214.37M
Current Assets Q1 2026 · Dec 31, 2025 $214.67M
Total Assets Q1 2026 · Mar 31, 2026 $587.73M
Total Assets Q1 2026 · Dec 31, 2025 $584.01M
Total Assets restated Q1 2026 · Mar 31, 2025 $586.24M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.02
Eps Diluted Q1 2026 · Mar 31, 2025 $0.00
Eps Basic Q1 2026 · Mar 31, 2026 −$0.02
Eps Basic Q1 2026 · Mar 31, 2025 $0.00
Sga Expense Q1 2026 · Mar 31, 2026 $14.72M
Sga Expense Q1 2026 · Mar 31, 2025 $13.65M
Net Income Q1 2026 · Mar 31, 2026 −$789K
Net Income Q1 2026 · Mar 31, 2025 −$154K
Operating Income Q1 2026 · Mar 31, 2026 $1.89M
Operating Income Q1 2026 · Mar 31, 2025 $4.42M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $102.07M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $99.47M
Revenue Q1 2026 · Mar 31, 2026 $121.8M
Revenue Q1 2026 · Mar 31, 2025 $123.59M